Fulgent Genetics Inc
(NQ:
FLGT
)
21.36
+0.17 (+0.80%)
Streaming Delayed Price
Updated: 10:58 AM EDT, Sep 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Fulgent Genetics Inc
< Previous
1
2
3
4
5
6
7
8
Next >
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Fulgent Genetics, Inc. (FLGT) on Behalf of Investors
August 05, 2022
From
Law Offices of Howard G. Smith
Via
Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Fulgent Genetics, Inc. (FLGT) on Behalf of Investors
August 05, 2022
From
The Law Offices of Frank R. Cruz
Via
Business Wire
Recap: Fulgent Genetics Q2 Earnings
August 04, 2022
Fulgent Genetics (NASDAQ:FLGT) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Fulgent Genetics beat...
Via
Benzinga
Fulgent Genetics Reports Second Quarter 2022 Financial Results
August 04, 2022
From
Fulgent Genetics, Inc.
Via
Business Wire
Why Fulgent Genetics Shares Are Trading Higher Today
April 19, 2022
Via
Benzinga
Recap: Fulgent Genetics Q4 Earnings
February 23, 2022
Fulgent Genetics (NASDAQ:FLGT) reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:00 PM. Here's what investors need to know about the announcement....
Via
Benzinga
Fulgent Genetics Welcomes Dr. Michael Nohaile and Dr. Leonard Post to Board of Directors
August 04, 2022
From
Fulgent Genetics, Inc.
Via
Business Wire
Fulgent Genetics Announces Launch of PCR Based Test to Detect Monkeypox
August 04, 2022
From
Fulgent Genetics, Inc.
Via
Business Wire
Fulgent Genetics to Announce Second Quarter 2022 Financial Results on Thursday, August 4, 2022
July 19, 2022
From
Fulgent Genetics, Inc.
Via
Business Wire
Fulgent Genetics: Q1 Earnings Insights
May 03, 2022
Fulgent Genetics (NASDAQ:FLGT) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Fulgent Genetics beat estimated...
Via
Benzinga
Fulgent Genetics Reports First Quarter 2022 Financial Results
May 03, 2022
From
Fulgent Genetics, Inc.
Via
Business Wire
Fulgent Genetics Announces Promotions and Leadership Updates
May 03, 2022
From
Fulgent Genetics, Inc.
Via
Business Wire
Fulgent Genetics Announces Opening of New State-of-the-Art Oncology Laboratory in El Monte, California
May 03, 2022
From
Fulgent Genetics, Inc.
Via
Business Wire
Earnings Outlook For Fulgent Genetics
May 02, 2022
Fulgent Genetics (NASDAQ:FLGT) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that Fulgent...
Via
Benzinga
Fulgent Genetics Agrees to Acquire Inform Diagnostics and Provides Preliminary First Quarter Revenue Results
April 18, 2022
From
Fulgent Genetics, Inc.
Via
Business Wire
Fulgent Genetics to Announce First Quarter 2022 Financial Results on Tuesday, May 3, 2022
April 18, 2022
From
Fulgent Genetics, Inc.
Via
Business Wire
These Are Ten Small Cap Stocks With Strong Buy Recommendations
March 27, 2022
One can reduce some risk by taking into account analyst recommendations. Stocks with strong buy recommendations are more likely to perform better than others. Let’s take a look at ten small cap stocks...
Via
Talk Markets
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
February 24, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adagio Appoints COO David Hering As Interim CEO Adagio Therapeutics, Inc., (...
Via
Benzinga
Fulgent Genetics Announces Strategic Investment in Spatial Genomics
February 23, 2022
From
Fulgent Genetics, Inc.
Via
Business Wire
Fulgent Genetics Reports Fourth Quarter and Full Year 2021 Financial Results
February 23, 2022
From
Fulgent Genetics, Inc.
Via
Business Wire
The Daily Biotech Pulse: Kodiak Sinks On Adverse Study Outcome, Marinus Flags Delay In Clinical Trial, Mainz Biomed Gains On Positive Regulatory Development
February 23, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Kodiak's Wet AMD Treatment KSI-301 Did Not Meet Primary Endpoint In Phase...
Via
Benzinga
Fulgent Genetics to Announce Fourth Quarter and Full Year 2021 Financial Results on Wednesday February 23, 2022
February 14, 2022
From
Fulgent Genetics, Inc.
Via
Business Wire
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front...
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
January 03, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our...
Via
Benzinga
Corona Doom 3.0: Omicron Surge. Profiting From The Boom In COVID-19 Testing Due To The Omicron Wave
December 22, 2021
COVID testing in a parking garage in Miami on Tuesday (photo via Jordan Levin). Good Luck Getting Into A Medical Clinic A woman we know got in a car accident over the...
Via
Benzinga
Corona Doom 3.0: Omicron Surge
December 22, 2021
One of the beneficiaries of the COVID testing boom is Fulgent Genetics, Inc.
Via
Talk Markets
5 Value Stocks In The Healthcare Sector
December 20, 2021
What is a Value Stock? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be...
Via
Benzinga
Is Fulgent Genetics a Good Healthcare Stock to Buy?
December 08, 2021
Shares fell earlier in the November, but popped again after a robust third-quarter earnings report.
Via
The Motley Fool
HelioLiver™, an Innovative Liquid Biopsy Test for the Early Detection of Liver Cancer, is Now Commercially Available
December 06, 2021
From
Fulgent Genetics, Inc.
Via
Business Wire
How Wide Is Fulgent Genetics' Moat?
December 03, 2021
The genetic testing company's moat is expanding.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.